Innovent Biologics, Inc. (OTCMKTS:IVBXF – Get Free Report)’s share price was up 4.2% on Friday . The company traded as high as $6.15 and last traded at $6.15. Approximately 3,484 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 13,781 shares. The stock had previously closed at $5.90.
Innovent Biologics Stock Performance
The firm’s fifty day moving average price is $5.02 and its 200-day moving average price is $5.02.
About Innovent Biologics
Innovent Biologics, Inc, a biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People's Republic of China. It offers Tyvyt, a human anti-PD-1 monoclonal antibody; BYVASDA, a fully-human anti-VEGF monoclonal antibody; HALPRYZA, a recombinant chimeric murine/human anti-CD20 monoclonal antibody; SULINNO, a fully-human antiTNF-a monoclonal antibody; Pemazyre, a selective FGFR inhibitor; Olverembatinib, a novel BCR-ABL TK; Cyramza, a VEGF receptor 2 antagonist; and Retsevmo, a selective and potent RET kinase inhibitor.
Featured Articles
- Five stocks we like better than Innovent Biologics
- How to Effectively Use the MarketBeat Ratings Screener
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- What is the Dow Jones Industrial Average (DJIA)?
- Disney 2025 Shareholders: Major Updates for Investors
- What is a Dividend King?
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Innovent Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovent Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
